Effect of calcitriol combined with calcium carbonate capsules on the efficacy, bone mineral density, electrolyte metabolism and safety of patients with diabetic osteoporosis

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400079635

Enrollment

Unknown

Registered

2024-01-08

Start date

2021-02-22

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic osteoporosis

Interventions

Control group:Calcium carbonate capsule 0.5g/ time, once/day

Observation group:Calcium carbonate capsule 0.5g/ time, once/day

Calcitriol softgel capsule 0.25µg/ time, once/day

Eligibility

Sex/Gender

All

Age

32 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Diagnosis of diabetes by referring to the Diagnosis and Treatment of Diabetes (2nd Edition); (2) The osteoporosis of DOP patients met the relevant diagnostic criteria in the Diagnostic Criteria for Primary Osteoporosis of Chinese People (Trial); (3) Age 30 ~ 86 years old, relevant treatment data and clinical records are complete; (4) The patient knows and understands all the contents of the informed consent and signs it voluntarily.

Exclusion criteria

Exclusion criteria: (1) Osteoporosis caused by related drugs; (2) acute fracture; (3) Diagnosis of diseases such as reduced or hyperparathyroidism; (4) Confirmed serious functional diseases of the heart, liver, kidney, etc.; (5) Intolerance or allergy to the drugs in this study; (6) Lost visitors.

Design outcomes

Primary

Measure	Time frame
Bone mineral density;	—

Secondary

Measure	Time frame
Blood calcium;Blood phosphorus;	—

Countries

China

Contacts

Public ContactYang Yanjun

Chizhou People's Hospital

416234420@qq.com+86 152 4992 1055

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026